Immunobiology Research Institute
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Immunobiology Research Institute sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,751 sponsors by registered trial count).
Immunobiology Research Institute: 7 sponsored US clinical trials, none currently recruiting.
Immunobiology Research Institute sponsors 7 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is HIV Infections, with 2 trials.
Upper-quartile sponsor footprint
Immunobiology Research Institute sits in the upper quartile of the sponsor corpus (#1,806 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
7 total, page 1 of 1
A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs
NCT00002332
Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002049
Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy
NCT00002109
A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients
NCT00002050
The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients
NCT00002289
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002066
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
NCT00002051
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
Therapeutic Areas
How the Immunobiology Research Institute archive is shaped
7 indexed studies, none listed as recruiting (0% open); 7 completed (100%).
Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).
Top condition: HIV Infections (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.